Woman appears to be cured of HIV after using new treatment, NIH says
The woman appears to be HIV-free following a new transplant method using umbilical cord blood.
Source: fox10phoenix.com
📰 Trial Network News
Page 10 - Trial Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trial Network. Real-time updates on events, politics, business and more.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial | Infectious Diseases | JAMA
This randomized trial assesses the effect of a single dose of subcutaneous casirivimab and imdevimab antibody combination vs placebo on 28-day progression to sy
Source: jamanetwork.com
IDSA Reading Room | Florence Momplaisir, MD, MSPH, on HIV, Perinatal Depression, and ART Adherence
It is well known that women living with the human immunodeficiency virus (HIV) are at but the impact of depressive symptoms on antiretroviral therapy (ART) adherence and viral suppression (VS) during pregnancy, and the postpartum period, is less clear. A multi-center group of researchers analyzed longitudinal data from 1,869 women enrolled in the International Maternal Pediatric Adolescent AIDS Clinical Trial Network (IMPAACT) P1025 Perinatal Core Protocol (2002-2013).
United States Florence Momplaisir Leonard Davis Institute Clinical Trials Group Quality Of Life Network Scholar Program International Maternal Pediatric Adolescent
Source: medpagetoday.com
INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18
INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18 - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
INOVIO Highlights Key Updates - GuruFocus.com
GuruFocus Article or News written by PRNewswire and the topic is about:
Source: gurufocus.com
INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from...
Source: prnewswire.com
INOVIO Announces Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from...
Source: prnewswire.com
INOVIO Announces Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from...
Source: prnewswire.com
INOVIO Expands Executive Leadership to Prepare for Commercial Operations
PLYMOUTH MEETING, Pa., Nov. 5, 2021 /PRNewswire/ -- INOVIO , a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious... | November 20, 2021
Source: marketscreener.com
INOVIO Expands Executive Leadership to Prepare for Commercial Operations
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from...
Source: prnewswire.com